Eye drop trial aims to heal damaged corneas
NCT ID NCT04485546
Summary
This study tested the safety and effectiveness of OXERVATE eye drops for treating an early stage of neurotrophic keratitis, a condition where the cornea doesn't heal properly due to nerve damage. Thirty-seven adult patients used the drops for 8 weeks and were followed for an additional 24 weeks. The main goal was to see if the drops helped heal the surface of the eye (cornea).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROTROPHIC KERATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston
Boston, Massachusetts, 02111, United States
-
Edgewood
Edgewood, Kentucky, 41017, United States
-
Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Saint Louis
St Louis, Missouri, 63131, United States
-
San Diego
San Diego, California, 92122, United States
Conditions
Explore the condition pages connected to this study.